The Recall Desk

FDA (Drugs) recall action 99204

Asclemed USA Inc. recalled 2 products on 2026-07-08

The FDA (Drugs) publishes a recall like this one as 2 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 2 pages.

Products
2
Announced
2026-07-08
Critical
0
Units

Why these products were recalled

Lack of Assurance of Sterility

The agency’s own wording, quoted from the enforcement report.

1–2 of 2

  • SevereFDA (Drugs)··2026-07-08

    Accucaine Lidocaine Injection Recalled for Lack of Sterility Assurance

    Asclemed USA Inc. is recalling specific lots of Accucaine (Lidocaine HCl Injection USP, 1%) distributed nationwide due to lack of assurance of sterility. The affected product is distributed by Enovachem Pharmaceuticals.

    Product
    ACCUCAINE (LIDOCAINE HYDROCHLORIDE)
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2026-07-08

    Lidocaine Hydrochloride Injection Recalled for Sterility Assurance

    Asclemed USA Inc. is recalling Lidocaine Hydrochloride Injection USP, 1% (10 mg/mL) in 5 mL single dose ampules nationwide due to lack of assurance of sterility. The affected lots have expiration dates of 11/30/2026 and 04/30/2028.

    Product
    LIDOCAINE HYDROCHLORIDE (LIDOCAINE HYDROCHLORIDE ANHYDROUS)
    Category
    Distribution
    0 states